Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

Trump's sweeping tariff measures have shaken the global economy, though, leaving many investors nursing huge losses.

Mobico shares today skidded 21% after the National Express owner announced the sale of its North American school bus ...

GSK said that IDRX-42 addresses all the key KIT ... has expanded its rare disease portfolio with the acquisition of France's Theravia for an undisclosed sum. The importance of biosimilars only ...

France, long recognized as a global leader in cosmetic innovation and export, plays a pivotal role in the retinoid market. The French retinoid industry is growing at the fastest pace in Europe, with a ...

Oncology Clinical Trial Market Roche is actively conducting pivotal trials for novel therapies targeting advanced breast cancer, aiming to ...